Vanda Pharmaceuticals (VNDA) Finished Goods (2014 - 2018)
Vanda Pharmaceuticals recorded quarterly Finished Goods of $1.0 million in Q1 2018, up 33.03% quarter-over-quarter from $760000.0 in Q4 2017, and up 31.98% year-over-year from $766000.0 in Q1 2017.
Vanda Pharmaceuticals' Finished Goods history runs 5 years deep, the most recent figure standing at $1.0 million for Q1 2018.
- In Q1 2018, Finished Goods rose 31.98% year-over-year to $1.0 million; the TTM figure through Mar 2018 stood at $1.0 million (up 31.98% YoY), while the FY2017 annual figure was $760000.0, changed 0.26% from the prior year.
- Finished Goods came in at $1.0 million for Q1 2018 at Vanda Pharmaceuticals, up from $760000.0 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $3.4 million in Q4 2014 to a low of $611000.0 in Q2 2017.
- A 5-year average of $1.5 million and a median of $941000.0 in 2014 frame the typical range for Finished Goods.
- On a YoY basis, Finished Goods climbed as much as 181.19% in 2015 and fell as far as 61.87% in 2015.
- Vanda Pharmaceuticals' Finished Goods stood at $3.4 million in 2014, then tumbled by 61.87% to $1.3 million in 2015, then plunged by 41.11% to $762000.0 in 2016, then slipped by 0.26% to $760000.0 in 2017, then soared by 33.03% to $1.0 million in 2018.
- According to Business Quant data, Finished Goods over the past three periods registered $1.0 million, $760000.0, and $858000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 1.01 Mn |
| Dec 31, 2017 | 760,000.00 |
| Sep 30, 2017 | 858,000.00 |
| Jun 30, 2017 | 611,000.00 |
| Mar 31, 2017 | 766,000.00 |
| Dec 31, 2016 | 762,000.00 |
| Dec 31, 2015 | 1.29 Mn |
| Sep 30, 2015 | 1.96 Mn |
| Jun 30, 2015 | 2.65 Mn |
| Mar 31, 2015 | 3.07 Mn |
| Dec 31, 2014 | 3.39 Mn |
| Sep 30, 2014 | 796,000.00 |
| Jun 30, 2014 | 941,000.00 |